Bill Sutherland
Analyst at Benchmark Company
Replay available
Cross Country Healthcare, Inc. (NASDAQ: CCRN) Q3 2023 earnings conference call, held 2023-11-01. Replay captured from the company's public earnings webcast.

Analyst at Benchmark Company
President and Chief Executive Officer
Analyst at Bank of America
President of Delivery
Vice President of Investor Relations
Analyst at Jefferies
Analyst at William Blair
Chief Commercial Officer
Analyst at Truist Securities
Chief Financial Officer
Good afternoon, everyone. Welcome to the Cross-Country Healthcare's earnings conference call for the third quarter 2023. Please be advised that this call is being recorded and a replay of this webcast will be available on the company's website. Details for accessing the audio replay can be found in the company's earnings release issued this afternoon. At the conclusion of the prepared remarks, I will open the lines for questions. I would now like to turn the call over to Josh Vogel, Cross-Country Healthcare's Vice President of Investor Relations. Thank you, and please go ahead, sir. Thank you, and good afternoon, everyone. I'm joined today by our President and Chief Executive Officer, John Martins, as well as Bill Burns, our Chief Financial Officer, Dan White, Chief Commercial Officer, and Mark Krug, President of Delivery. Today's call will include a discussion of our financial results for the third quarter of 2023, as well as our outlook for the fourth quarter. A copy of our earnings press release is available on our website at crosscountry.com. Please note that certain statements made on this call may constitute forward-looking statements. These statements reflect the company's beliefs based upon information currently available to it. As noted in our press release today, forward-looking statements can vary materially from actual results and are subject to known and unknown risks, uncertainties, and other factors, including those contained in the company's 2022 annual report on Form 10-K and quarterly reports on Form 10Q, as well as in other filings with the SEC. The company does not intend to update guidance or any of its forward-looking statements prior to the next earnings release. Additionally, we reference non-GAAP financial measures such as adjusted EBITDA or ...